Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors. | Front Oncol | 2022 | 35747820 | PubTator, text mining | PubMed |
| Cellular Aquaculture: Prospects and Challenges. | Micromachines (Basel) | 2022 | 35744442 | PubTator, text mining | PubMed |
| CFTR and Gastrointestinal Cancers: An Update. | J Pers Med | 2022 | 35743652 | PubTator, text mining | PubMed |
| Identifying the Potential Roles of PBX4 in Human Cancers Based on Integrative Analysis. | Biomolecules | 2022 | 35740947 | PubTator, text mining | PubMed |
| Enrichment of cancer-predisposing germline variants in adult and pediatric patients with acute lymphoblastic leukemia. | Sci Rep | 2022 | 35739278 | PubTator, text mining | PubMed |
| Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients. | Medeni Med J | 2022 | 35734982 | PubTator, text mining | PubMed |
Spectrum of germline pathogenic variants using a targeted next generation sequencing panel and genotype-phenotype correlations in patients with suspected hereditary breast cancer at an academic medical centre in Pakistan. | Hered Cancer Clin Pract | 2022 | 35710434 | PubTator, text mining | PubMed |
| Miniaturized Chemical Tags for Optical Imaging. | Angew Chem Int Ed Engl | 2022 | 35704518 | PubTator, text mining | PubMed |
| Case Report: Male Lobular Breast Cancer in Hereditary Cancer Syndromes. | Front Oncol | 2022 | 35686104 | PubTator, text mining | PubMed |
| Pharmacogenetic Review: Germline Genetic Variants Possessing Increased Cancer Risk With Clinically Actionable Therapeutic Relationships. | Front Genet | 2022 | 35685436 | PubTator, text mining | PubMed |
| Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy. | Cells | 2022 | 35681550 | PubTator, text mining | PubMed |
| Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system. | Cancer | 2022 | 35679147 | PubTator, text mining | PubMed |
| The Emergence of Virtual Tumor Boards in Neuro-Oncology: Opportunities and Challenges. | Cureus | 2022 | 35677741 | PubTator, text mining | PubMed |
| Young transgenic hMTH1 mice are protected against dietary fat-induced metabolic stress-implications for enhanced longevity. | Aging Cell | 2022 | 35670027 | PubTator, text mining | PubMed |
| Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures. | Nat Commun | 2022 | 35668106 | PubTator, text mining | PubMed |
| The Interplay of Four Main Pathways Recomposes Immune Landscape in Primary and Metastatic Gastroenteropancreatic Neuroendocrine Tumors. | Front Oncol | 2022 | 35664743 | PubTator, text mining | PubMed |
| Complete response to pembrolizumab in a patient with dermatomyositis and MMR deficient ovarian cancer: A case report. | Gynecol Oncol Rep | 2022 | 35663849 | PubTator, text mining | PubMed |
| Concordance of hydrogen peroxide-induced 8-oxo-guanine patterns with two cancer mutation signatures of upper GI tract tumors. | Sci Adv | 2022 | 35658030 | PubTator, text mining | PubMed |
| Heterogeneous Skeletal Muscle Cell and Nucleus Populations Identified by Single-Cell and Single-Nucleus Resolution Transcriptome Assays. | Front Genet | 2022 | 35646075 | PubTator, text mining | PubMed |
| Case Report: A Chinese Family of Type A Insulin Resistance Syndrome With Diabetes Mellitus, With a Novel Heterozygous Missense Mutation of the Insulin Receptor Gene. | Front Endocrinol (Lausanne) | 2022 | 35634501 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=43